These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22591839)

  • 1. Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010-2011 season.
    Kourti A; Spanakos G; Politi L; Stavropoulou A; Spanakis N; Tsakris A
    Int J Antimicrob Agents; 2012 Jul; 40(1):72-4. PubMed ID: 22591839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
    Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.
    Longtin J; Patel S; Eshaghi A; Lombos E; Higgins R; Alexander D; Olsha R; Doyle J; Tran D; Sarabia A; Lee C; Bastien N; Li Y; Low D; Boivin G; Gubbay J
    J Clin Virol; 2011 Mar; 50(3):257-61. PubMed ID: 21251873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.
    Chidlow GR; Harnett GB; Williams SH; Tempone SS; Speers DJ; Hurt AC; Deng YM; Smith DW
    J Virol Methods; 2010 Oct; 169(1):47-51. PubMed ID: 20600329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pacific region influenza surveillance for oseltamivir resistance.
    Miller HB; Gose RB; Nagata MT; Sciulli RH; Whelen AC
    J Clin Virol; 2012 May; 54(1):73-5. PubMed ID: 22296793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.
    Hindiyeh M; Ram D; Mandelboim M; Meningher T; Hirsh S; Robinov J; Levy V; Orzitzer S; Azar R; Grossman Z; Mendelson E
    J Clin Microbiol; 2010 May; 48(5):1884-7. PubMed ID: 20220153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011.
    Arvia R; Corcioli F; Simi L; Orlando C; De Santis R; Facchini M; Donatelli I; Azzi A
    J Virol Methods; 2012 Sep; 184(1-2):113-6. PubMed ID: 22659066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.
    Ciblak MA; Hasoksuz M; Escuret V; Valette M; Gul F; Yilmaz H; Turan N; Bozkaya E; Badur S
    J Med Virol; 2009 Sep; 81(9):1645-51. PubMed ID: 19626608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
    Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
    J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
    Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
    Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
    Ngai KL; Lam WY; Lee N; Leung TF; Hui DS; Chan PK
    J Med Virol; 2010 Aug; 82(8):1295-8. PubMed ID: 20572070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon.
    Zaraket H; Kondo H; Tabet C; Hanna-Wakim R; Suzuki Y; Dbaibo GS; Saito R; Suzuki H
    J Clin Virol; 2011 Jul; 51(3):170-4. PubMed ID: 21565547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
    Antón A; López-Iglesias AA; Tórtola T; Ruiz-Camps I; Abrisqueta P; Llopart L; Marcos MÁ; Martínez MJ; Tudó G; Bosch F; Pahissa A; de Anta MT; Pumarola T
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):214-9. PubMed ID: 20955912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.